Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
- 6 May 2020
- journal article
- research article
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (7), 2263-2274.e5
- https://doi.org/10.1016/j.jaip.2020.02.042
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 38 references indexed in Scilit:
- The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysisJournal of Allergy and Clinical Immunology, 2013
- Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation studyPrimary Care Respiratory Journal, 2012
- Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescentsJournal of Allergy and Clinical Immunology, 2012
- Does asthma control as assessed by the asthma control test reflect airway inflammation?Multidisciplinary Respiratory Medicine, 2011
- Association of Exhaled Nitric Oxide to Asthma Burden in Asthmatics on Inhaled CorticosteroidsJournal of Asthma, 2010
- Asthma Control Questionnaire in children: validation, measurement properties, interpretationEuropean Respiratory Journal, 2010
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- The Asthma Therapy Assessment Questionnaire (ATAQ) for Children and AdolescentsDisease Management, 2004
- Factors associated with hospital admissions and repeat emergency department visits for adults with asthmaThorax, 2000